| Literature DB >> 31708983 |
Piotr Duchnowski1, Tomasz Hryniewiecki1, Mariusz Kuśmierczyk1, Piotr Szymański1.
Abstract
AIM: The aim of the study was to assess the usefulness of lactate blood levels in the perioperative period in patients undergoing heart valve surgery.Entities:
Keywords: lactate; postoperative strategy; risk stratification; valve surgery
Year: 2019 PMID: 31708983 PMCID: PMC6836636 DOI: 10.5114/kitp.2019.88599
Source DB: PubMed Journal: Kardiochir Torakochirurgia Pol ISSN: 1731-5530
Baseline characteristics of study population
| Parameter | Values |
|---|---|
| Preoperative characteristics of patients ( | |
| Age [years] | 63.1 ±12.9 |
| Male: men, | 461 (57) |
| Body mass index [kg/m2] | 27.3 ±9.1 |
| NYHA, (classes) | 2.6 ±0.5 |
| LV ejection fraction (%) | 56 ±11 |
| EuroSCORE (%) | 6.2 ±4.8 |
| EuroSCORE II (%) | 3.8 ±3.4 |
| STS (%) | 3.6 ±3.0 |
| Atrial fibrillation | 347 (43) |
| Coronary artery disease, | 111 (13) |
| Chronic obstructive airways disease, | 52 (6) |
| Chronic kidney disease (GFR < 60 ml/min/1.73 m2), | 245 (30) |
| Diabetes mellitus, | 133 (16) |
| Hypertension, | 510 (63) |
| Peripheral atherosclerosis, | 43 (5) |
| Creatinine [mg/dl] | 1 ±0.4 |
| Hemoglobin [g/dl] | 13.5 ±1.5 |
| Intraoperative characteristics of patients: | |
| Aortic cross-clamp time [min] | 94 ±40 |
| Cardiopulmonary bypass time [min] | 122 ±53 |
| Postoperative characteristics of patients: | |
| Lactates [mmol/l] | 1.7 ±0.4 |
| Lactates I [mmol/l] | 2.2 ±1 |
| Lactates II [mmol/l] | 2.6 ±2 |
| pH | 7.4 ±0.07 |
| pH I | 7.32 ±0.2 |
| pH II | 7.34 ±0.1 |
| Creatinine II [mg/dl] | 1.3 ±0.4 |
| Hemoglobin II [g/dl] | 10.4 ±1.4 |
| Main procedures: | |
| AVR, | 401 (50) |
| AVP, | 30 (2.6) |
| MVR, | 161 (19.7) |
| MVR + AVR, | 60 (8.4) |
| MVP, | 149 (14.6) |
| Concomitant procedures: | |
| CABG, | 110 (13) |
Values are represented as the mean
and a measure of the variation of the internal standard deviation.
AVP – aortic valve plasty, AVR – aortic valve replacement, MVP – mitral valve plasty, MVR – mitral valve replacement, GFR – glomerular filtration rate, LV – left ventricle, NYHA – New York Heart Association. Creatinine – creatinine measured one day before operation, Creatinine II – creatinine measured one day after operation (18 hours after operation), Hemoglobin – hemoglobin measured one day before operation, Hemoglobin II – hemoglobin measured one day after operation (18 hours after operation), Lactates – lactates measured immediately after operation, pH – pH measured immediately after operation, Lactates I – lactates measured 6 hours after operation, pH I – pH measured 6 hours after operation, Lactates II – lactates measured one day after operation (18 hours after operation), pH II – pH measured 1 day after operation (18 hours after operation).
Univariate analysis of predictive factors for occurrence of death
| Variable | Odds ratio | 95% CI | |
|---|---|---|---|
| Age [years] | 1.085 | 1.047–1.125 | < 0.0001 |
| Lac I [mmol/l] | 2.001 | 1.427–2.803 | < 0.001 |
| Lac II [mmol/l] | 1.813 | 1.377–3.389 | < 0.0001 |
| pH II | 1.130 | 1.053–1.186 | < 0.0001 |
| Hemoglobin [g/dl] | 0.569 | 0.469–0.690 | < 0.0001 |
| LV ejection fraction, % | 0.972 | 0.951–0.993 | 0.01 |
Hemoglobin – hemoglobin measured 1 day before operation, Hemoglobin II – hemoglobin measured 1 day after operation (18 hours after operation), Lac I – lactates measured 6 hours after operation, Lac II – lactates measured 1 day after operation (18 hours after operation), pH II – pH measured 1 day after operation (18 hours after operation).
Figure 1Area under receiver operating characteristic (ROC) curve of lactate blood level measured one day after surgery for death following valve replacement/repair surgery